DGCI approved Biocon drug to be used for treatment of moderate to severe COVID-19 patients
July 13, 2020 18:26 ISTThe executive chairperson of Biocon, Kiran Mazumdar Shaw said, "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release distress syndrome (ADRS) patients caused by the COVID-19".